Carolina Molecular Inc.

CIK 2096691 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Carolina Molecular Inc..

Recent SEC filings

FiledFormAccession number
Nov 13, 2025D0002096691-25-000001